Table 4. Model components.
| Protein | PDB code | ASU† | Ordered residues by chain | Waters | Ligands‡ |
|---|---|---|---|---|---|
| D499N | 6nn4 | 4 | A: 23–111, 117–130, 229–543 | 353 | 4 Fru-1,6-BP, 4 phosphoenolpyruvate, 7 ethylene glycol |
| B: 24–110, 117–130, 231–543 | |||||
| C: 15–110, 117–130, 233–529, 532–543 | |||||
| D: 24–110, 117–133, 233–530, 532–543 | |||||
| W527H | 6nn5 | 4 | A: 18–110, 117–129, 233–543 | 195 | 10 ethylene glycol, 12 glycerol |
| B: 23–110, 117–133, 232–543 | |||||
| C: 26–111, 116–129, 230–542 | |||||
| D: 23–111, 114–129, 229–543 | |||||
| GGG | 6nn7 | 8 | A: 16–137, 142–201, 205–527, 533–543 | 382 | 2 citrate, 17 ethylene glycol, 14 glycerol |
| B: 26–132, 232–527, 533–543 | |||||
| C: 27–114, 117–543 | |||||
| D: 23–134, 142–148, 153–158, 163–176, 179–181, 186–195, 198–200, 211–224, 233–543 | |||||
| E: 25–543 | |||||
| F: 25–111, 116–131, 233–525, 534–543 | |||||
| G: 15–111, 117–135, 145–202, 205–213, 218–224, 233–527, 533–543 | |||||
| H: 27–110, 113–129, 234–490, 495–525, 534–542 | |||||
| S531E | 6nn8 | 8 | A: 20–133, 144–155, 165–543 | 250 | 42 ethylene glycol |
| B: 23–138, 141–542 | |||||
| C: 18–135, 143–156, 166–200, 205–225, 233–543 | |||||
| D: 13–89, 92–129, 238–543 | |||||
| E: 23–137, 144–490, 494–529, 533–543 | |||||
| F: 22–110, 117–131, 230–529, 531–543 | |||||
| G: 20–89, 94–112, 116–130, 250–529, 533–543 | |||||
| H: 24–89, 92–110, 116–133, 236–243, 247–529, 53–543 |
Number of monomers in the asymmetric unit.
Ethylene glycol was used as a cryoprotectant, citrate was in the well solution and glycerol was in the protein buffer.